Tweet
Urgent guidance, approach to identify patients at risk of drug-induced sudden cardiac death from use of off-label COVID-19 treatments
Date:March 25, 2020Source:Mayo ClinicSummary:Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. Patients with a dangerously prolonged QTc are at increased risk for potentially life-threatening ventricular rhythm abnormalities that can culminate in sudden cardiac death. A new study details more information about potential dangers and the application of QTc monitoring to guide treatment when using drugs that can cause heart rhythm changes.
Date:March 25, 2020Source:Mayo ClinicSummary:Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. Patients with a dangerously prolonged QTc are at increased risk for potentially life-threatening ventricular rhythm abnormalities that can culminate in sudden cardiac death. A new study details more information about potential dangers and the application of QTc monitoring to guide treatment when using drugs that can cause heart rhythm changes.